Superficial granulomatous pyoderma - Revision history

Prab: CSV import

2025-04-04T02:21:12Z

CSV import

← Older revision		Revision as of 02:21, 4 April 2025
Line 1:		Line 1:

			{{Infobox medical condition
			\| name = Superficial granulomatous pyoderma
			\| synonyms = [[Pyoderma vegetans]]
			\| specialty = [[Dermatology]]
			\| symptoms = [[Ulcer]]s, [[granuloma]]tous inflammation
			\| complications = [[Infection]], [[scarring]]
			\| onset = Variable
			\| duration = Chronic
			\| causes = Unknown, possibly [[immune system]] dysfunction
			\| risks = [[Immunosuppression]], [[autoimmune disease]]
			\| diagnosis = [[Clinical diagnosis]], [[biopsy]]
			\| differential = [[Pyoderma gangrenosum]], [[cutaneous tuberculosis]], [[deep fungal infection]]
			\| treatment = [[Corticosteroids]], [[immunosuppressive therapy]]
			\| prognosis = Variable, can be chronic
			\| frequency = Rare
			}}
	'''Superficial Granulomatous Pyoderma''' (SGP) is a rare, chronic skin condition that falls under the broader category of [[pyoderma gangrenosum]]. It is characterized by the presence of superficial, granulomatous ulcerations that typically affect the trunk and extremities. Unlike classic [[pyoderma gangrenosum]], SGP tends to have a more benign course and responds better to treatment.		'''Superficial Granulomatous Pyoderma''' (SGP) is a rare, chronic skin condition that falls under the broader category of [[pyoderma gangrenosum]]. It is characterized by the presence of superficial, granulomatous ulcerations that typically affect the trunk and extremities. Unlike classic [[pyoderma gangrenosum]], SGP tends to have a more benign course and responds better to treatment.

	==Etiology and Pathogenesis==		==Etiology and Pathogenesis==
	The exact cause of Superficial Granulomatous Pyoderma remains unknown, but it is believed to be an immune-mediated condition. It may be associated with systemic diseases such as [[inflammatory bowel disease]], [[arthritis]], and [[hematologic disorders]]. The pathogenesis involves an abnormal immune response, leading to inflammation and the formation of granulomas in the skin.		The exact cause of Superficial Granulomatous Pyoderma remains unknown, but it is believed to be an immune-mediated condition. It may be associated with systemic diseases such as [[inflammatory bowel disease]], [[arthritis]], and [[hematologic disorders]]. The pathogenesis involves an abnormal immune response, leading to inflammation and the formation of granulomas in the skin.

	==Clinical Features==		==Clinical Features==
	SGP presents as single or multiple, well-demarcated, shallow ulcers with a granular base. The lesions are often surrounded by a violaceous or erythematous border. Patients may report minimal pain or discomfort. The condition predominantly affects adults, but cases in children have been reported.		SGP presents as single or multiple, well-demarcated, shallow ulcers with a granular base. The lesions are often surrounded by a violaceous or erythematous border. Patients may report minimal pain or discomfort. The condition predominantly affects adults, but cases in children have been reported.

	==Diagnosis==		==Diagnosis==
	Diagnosis of Superficial Granulomatous Pyoderma is primarily clinical, supported by histopathological findings. A biopsy of the lesion typically shows a superficial granulomatous inflammation without the deep ulceration seen in classic pyoderma gangrenosum. Direct immunofluorescence studies are usually negative, helping to differentiate SGP from other dermatological conditions.		Diagnosis of Superficial Granulomatous Pyoderma is primarily clinical, supported by histopathological findings. A biopsy of the lesion typically shows a superficial granulomatous inflammation without the deep ulceration seen in classic pyoderma gangrenosum. Direct immunofluorescence studies are usually negative, helping to differentiate SGP from other dermatological conditions.

	==Treatment==		==Treatment==
	Treatment options for SGP include topical and intralesional corticosteroids, which are often effective. Systemic treatments, such as oral corticosteroids, dapsone, or immunosuppressants, may be considered in more severe or refractory cases. Complete healing of the lesions can be achieved, but recurrence is possible.		Treatment options for SGP include topical and intralesional corticosteroids, which are often effective. Systemic treatments, such as oral corticosteroids, dapsone, or immunosuppressants, may be considered in more severe or refractory cases. Complete healing of the lesions can be achieved, but recurrence is possible.

	==Prognosis==		==Prognosis==
	The prognosis for Superficial Granulomatous Pyoderma is generally favorable, with most patients responding well to treatment. The condition tends to have a chronic relapsing course, but long-term complications are rare.		The prognosis for Superficial Granulomatous Pyoderma is generally favorable, with most patients responding well to treatment. The condition tends to have a chronic relapsing course, but long-term complications are rare.

	==See Also==		==See Also==
	* [[Pyoderma Gangrenosum]]		* [[Pyoderma Gangrenosum]]
Line 21:		Line 32:
	* [[Dermatology]]		* [[Dermatology]]
	* [[Inflammatory Bowel Disease]]		* [[Inflammatory Bowel Disease]]

	[[Category:Dermatology]]		[[Category:Dermatology]]
	[[Category:Skin Conditions]]		[[Category:Skin Conditions]]
	[[Category:Immune System Disorders]]		[[Category:Immune System Disorders]]

	{{medicine-stub}}		{{medicine-stub}}
	{{No image}}		{{No image}}
	~~__NOINDEX__~~

Prab: CSV import

2025-03-18T01:26:14Z

CSV import

← Older revision		Revision as of 01:26, 18 March 2025
Line 28:		Line 28:
	{{medicine-stub}}		{{medicine-stub}}
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-11T05:24:48Z

CSV import

← Older revision		Revision as of 05:24, 11 February 2025
Line 27:		Line 27:

	{{medicine-stub}}		{{medicine-stub}}
			{{No image}}

Prab: CSV import

2024-03-31T14:37:23Z

CSV import

New page

'''Superficial Granulomatous Pyoderma''' (SGP) is a rare, chronic skin condition that falls under the broader category of [[pyoderma gangrenosum]]. It is characterized by the presence of superficial, granulomatous ulcerations that typically affect the trunk and extremities. Unlike classic [[pyoderma gangrenosum]], SGP tends to have a more benign course and responds better to treatment.

==Etiology and Pathogenesis==
The exact cause of Superficial Granulomatous Pyoderma remains unknown, but it is believed to be an immune-mediated condition. It may be associated with systemic diseases such as [[inflammatory bowel disease]], [[arthritis]], and [[hematologic disorders]]. The pathogenesis involves an abnormal immune response, leading to inflammation and the formation of granulomas in the skin.

==Clinical Features==
SGP presents as single or multiple, well-demarcated, shallow ulcers with a granular base. The lesions are often surrounded by a violaceous or erythematous border. Patients may report minimal pain or discomfort. The condition predominantly affects adults, but cases in children have been reported.

==Diagnosis==
Diagnosis of Superficial Granulomatous Pyoderma is primarily clinical, supported by histopathological findings. A biopsy of the lesion typically shows a superficial granulomatous inflammation without the deep ulceration seen in classic pyoderma gangrenosum. Direct immunofluorescence studies are usually negative, helping to differentiate SGP from other dermatological conditions.

==Treatment==
Treatment options for SGP include topical and intralesional corticosteroids, which are often effective. Systemic treatments, such as oral corticosteroids, dapsone, or immunosuppressants, may be considered in more severe or refractory cases. Complete healing of the lesions can be achieved, but recurrence is possible.

==Prognosis==
The prognosis for Superficial Granulomatous Pyoderma is generally favorable, with most patients responding well to treatment. The condition tends to have a chronic relapsing course, but long-term complications are rare.

==See Also==
* [[Pyoderma Gangrenosum]]
* [[Granuloma]]
* [[Dermatology]]
* [[Inflammatory Bowel Disease]]

[[Category:Dermatology]]
[[Category:Skin Conditions]]
[[Category:Immune System Disorders]]

{{medicine-stub}}